Valentina Molteni
Genomics Institute of the Novartis Research Foundation(US)
Publications by Year
Research Areas
Synthesis of β-Lactam Compounds, Research on Leishmaniasis Studies, Trypanosoma species research and implications, Chemical Synthesis and Analysis, Synthesis and Catalytic Reactions
Most-Cited Works
- → The nuclear receptor LXR is a glucose sensor(2006)512 cited
- → Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness(2016)408 cited
- → Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis(2014)337 cited
- → Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)(2017)225 cited
- → One-Pot Electrochemical Nickel-Catalyzed Decarboxylative Sp2–Sp3 Cross-Coupling(2019)113 cited
- → Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases(2020)111 cited
- → Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis(2020)97 cited
- → Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models(2012)96 cited
- → Tropifexor‐Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents(2019)90 cited
- → Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain(2001)87 cited